Steven Cohen’s Tyra Biosciences TYRA Stock Holding History

Steven Cohen’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-180,100	Closed	-$6.9M	–	4603
2026 Q1	$6.9M	Buy	+180,100	New	+$5.83M	0.01%	1481

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Steven Cohen's TYRA Position: Q2 2026 in Review

Steven Cohen sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 38,850 shares — an estimated $1.49M sold.

Steven Cohen first reported a position in TYRA in Q4 2024 and held it in 6 quarters. The position peaked at $23M in Q4 2025. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

Steven Cohen reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
Steven Cohen sold 38,850 Tyra Biosciences shares in Q2 2026, an estimated $1.49M.
Steven Cohen first reported a position in Tyra Biosciences in Q4 2024 and held it in 6 quarters.
Steven Cohen's Tyra Biosciences position peaked at $23M in Q4 2025.
169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.